NO20021281L - Vaskul¶r beleggingssammensetning - Google Patents

Vaskul¶r beleggingssammensetning

Info

Publication number
NO20021281L
NO20021281L NO20021281A NO20021281A NO20021281L NO 20021281 L NO20021281 L NO 20021281L NO 20021281 A NO20021281 A NO 20021281A NO 20021281 A NO20021281 A NO 20021281A NO 20021281 L NO20021281 L NO 20021281L
Authority
NO
Norway
Prior art keywords
wash
investment composition
investment
composition
coating
Prior art date
Application number
NO20021281A
Other languages
English (en)
Other versions
NO20021281D0 (no
Inventor
Jeremy Ollerenshaw
Uemit Yueksel
Kirby S Black
Original Assignee
Cryolife Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cryolife Inc filed Critical Cryolife Inc
Publication of NO20021281D0 publication Critical patent/NO20021281D0/no
Publication of NO20021281L publication Critical patent/NO20021281L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3625—Vascular tissue, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/92—Method or apparatus for preparing or treating prosthetic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/92—Method or apparatus for preparing or treating prosthetic
    • Y10S623/921—Blood vessel

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Botany (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)
  • Paints Or Removers (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse angår fremgangsmåter for belegging av den luminale overflaten til et blodkar eller annen vevshule og sammensetninger som passer for anvendelse i samme.
NO20021281A 1999-09-15 2002-03-14 Vaskul¶r beleggingssammensetning NO20021281L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15395099P 1999-09-15 1999-09-15
PCT/US2000/025310 WO2001019347A1 (en) 1999-09-15 2000-09-15 Vascular coating composition

Publications (2)

Publication Number Publication Date
NO20021281D0 NO20021281D0 (no) 2002-03-14
NO20021281L true NO20021281L (no) 2002-03-26

Family

ID=22549391

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021281A NO20021281L (no) 1999-09-15 2002-03-14 Vaskul¶r beleggingssammensetning

Country Status (10)

Country Link
US (2) US6372229B1 (no)
EP (1) EP1214057B1 (no)
JP (1) JP2003509362A (no)
AT (1) ATE446776T1 (no)
AU (1) AU769136B2 (no)
CA (1) CA2385150C (no)
DE (1) DE60043229D1 (no)
HK (1) HK1047404B (no)
NO (1) NO20021281L (no)
WO (1) WO2001019347A1 (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE446776T1 (de) * 1999-09-15 2009-11-15 Cryolife Inc Zusammensetzung zur gefässbeschichtung
US20040018228A1 (en) * 2000-11-06 2004-01-29 Afmedica, Inc. Compositions and methods for reducing scar tissue formation
US9101536B2 (en) * 2002-08-06 2015-08-11 Matrix Medical Llc Biocompatible phase invertable proteinaceous compositions and methods for making and using the same
US10098981B2 (en) 2002-08-06 2018-10-16 Baxter International Inc. Biocompatible phase invertable proteinaceous compositions and methods for making and using the same
ES2703438T3 (es) * 2002-08-06 2019-03-08 Baxter Int Composiciones proteicas de fase reversible biocompatible y métodos para prepararlas y usarlas
US8349348B2 (en) * 2002-08-06 2013-01-08 Matrix Medical, Llc Biocompatible phase invertible proteinaceous compositions and methods for making and using the same
DE10236152A1 (de) * 2002-08-07 2004-02-19 Marker Deutschland Gmbh Ski- und Skibindungs-Kombination
US7803150B2 (en) * 2004-04-21 2010-09-28 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
JP4767252B2 (ja) 2004-06-14 2011-09-07 ヌームアールエックス・インコーポレーテッド 肺のアクセス装置
US7553810B2 (en) * 2004-06-16 2009-06-30 Pneumrx, Inc. Lung volume reduction using glue composition
US20050281799A1 (en) 2004-06-16 2005-12-22 Glen Gong Targeting damaged lung tissue using compositions
US20050281798A1 (en) * 2004-06-16 2005-12-22 Glen Gong Targeting sites of damaged lung tissue using composition
US20050281740A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue
US20050288702A1 (en) * 2004-06-16 2005-12-29 Mcgurk Erin Intra-bronchial lung volume reduction system
US7608579B2 (en) * 2004-06-16 2009-10-27 Pneumrx, Inc. Lung volume reduction using glue compositions
US7678767B2 (en) 2004-06-16 2010-03-16 Pneumrx, Inc. Glue compositions for lung volume reduction
US20050281739A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue using compositions
EP1781182B1 (en) * 2004-07-08 2019-11-13 PneumRx, Inc. Pleural effusion treatment device
US7766891B2 (en) 2004-07-08 2010-08-03 Pneumrx, Inc. Lung device with sealing features
EP1816945B1 (en) 2004-11-23 2019-08-21 PneumRx, Inc. Steerable device for accessing a target site
US20070014830A1 (en) * 2005-06-08 2007-01-18 Tijsma Edze J Drug-releasing sinus stent
US20070110788A1 (en) * 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
US8157837B2 (en) 2006-03-13 2012-04-17 Pneumrx, Inc. Minimally invasive lung volume reduction device and method
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US8888800B2 (en) 2006-03-13 2014-11-18 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US7993675B2 (en) * 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US7959943B2 (en) * 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US7976873B2 (en) * 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
CA2663417A1 (en) * 2006-09-13 2008-03-20 Southeastern Medical Technologies, Llc Methods and compositions for sealing and adhering biological tissues and medical uses thereof
WO2008036763A2 (en) * 2006-09-20 2008-03-27 Pneumrx, Inc. Tissue adhesive compositions and methods thereof
US8088095B2 (en) * 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
US20090011043A1 (en) * 2007-07-03 2009-01-08 Hua Xie Tissue sealant made from whole blood
CA2706701C (en) 2007-12-03 2016-10-25 Tenaxis Medical, Inc. Biocompatible phase invertible proteinaceous compositions
AU2009257390B2 (en) 2008-06-12 2014-09-04 Medtronic Xomed, Inc. Method for treating chronic wounds with an extracellular polymeric substance solvating system
US8632605B2 (en) 2008-09-12 2014-01-21 Pneumrx, Inc. Elongated lung volume reduction devices, methods, and systems
US9155815B2 (en) 2009-04-17 2015-10-13 Tenaxis Medical, Inc. Biocompatible phase invertible proteinaceous compositions and methods for making and using the same
JP5809621B2 (ja) 2009-05-18 2015-11-11 ヌームアールエックス・インコーポレーテッド 患者の肺を治療するインプラント
US20110077216A1 (en) * 2009-09-30 2011-03-31 Massachusetts Institute Of Technology Compositions and methods for the treatment of atherosclerosis and other related diseases
US10390838B1 (en) 2014-08-20 2019-08-27 Pneumrx, Inc. Tuned strength chronic obstructive pulmonary disease treatment
WO2019231763A1 (en) 2018-05-27 2019-12-05 Christos Angeletakis Tissue adhesives and sealants using naturally derived aldehydes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4247406A (en) 1979-04-23 1981-01-27 Widder Kenneth J Intravascularly-administrable, magnetically-localizable biodegradable carrier
US4979959A (en) * 1986-10-17 1990-12-25 Bio-Metric Systems, Inc. Biocompatible coating for solid surfaces
US5213580A (en) * 1988-08-24 1993-05-25 Endoluminal Therapeutics, Inc. Biodegradable polymeric endoluminal sealing process
EP0649637A1 (en) * 1988-08-24 1995-04-26 SLEPIAN, Marvin J. Material for endoluminal paving and sealing
US5843156A (en) * 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
US5654267A (en) * 1988-12-20 1997-08-05 La Jolla Cancer Research Center Cooperative combinations of ligands contained within a matrix
CA2070149A1 (en) * 1991-06-04 1992-12-05 Stephen J. Boccuzzi Hmg-coa reductase inhibitors in the prevention of restenosis following coronary angloplasty
US5385606A (en) * 1992-07-06 1995-01-31 Kowanko; Nicholas Adhesive composition and method
US5914345A (en) * 1994-10-11 1999-06-22 Endoluminal Therapeutics, Inc. Treatment of tissues to reduce subsequent response to injury
US5900245A (en) * 1996-03-22 1999-05-04 Focal, Inc. Compliant tissue sealants
ATE446776T1 (de) * 1999-09-15 2009-11-15 Cryolife Inc Zusammensetzung zur gefässbeschichtung

Also Published As

Publication number Publication date
HK1047404A1 (en) 2003-02-21
US6849262B2 (en) 2005-02-01
US20020183244A1 (en) 2002-12-05
CA2385150A1 (en) 2001-03-22
AU769136B2 (en) 2004-01-15
NO20021281D0 (no) 2002-03-14
EP1214057B1 (en) 2009-10-28
ATE446776T1 (de) 2009-11-15
WO2001019347A1 (en) 2001-03-22
EP1214057A1 (en) 2002-06-19
DE60043229D1 (de) 2009-12-10
AU7381100A (en) 2001-04-17
CA2385150C (en) 2010-11-23
HK1047404B (zh) 2010-05-20
US6372229B1 (en) 2002-04-16
JP2003509362A (ja) 2003-03-11
EP1214057A4 (en) 2006-03-29

Similar Documents

Publication Publication Date Title
NO20021281L (no) Vaskul¶r beleggingssammensetning
ATE305788T1 (de) (s,s)-reboxetin zur behandlung von inkontinenz
DE60038922D1 (de) Zusammensetzungen für den wiederaufbau von knochengewebe
ATE300597T1 (de) Behandlung von geweben
DE50011194D1 (de) Medizinisches Instrument zum Präparieren von Gewebe
WO2000071493A3 (en) INHIBITORS OF FACTOR Xa
MX9606386A (es) Agentes que afectan la hemostasis trombotica.
TR200200068T2 (tr) Nematisital triflüorobütenler
DE60028863D1 (de) Elektrochirurgisches Handstück zur Behandlung von Gewebe
BR0014560B1 (pt) uso de uma composiÇço de tratamento de tecidos.
DE60112807D1 (de) Zusammensetzung zur behandlung von durch arterielle irrigationsdefekt gewebeschäden
ATE273690T1 (de) Zusammensetzung zur hautdesinfizierung
BR0213072A (pt) Sabonete em barra
DE60001555D1 (de) Wässrige lösung zum konservieren von gewebe und organen
EE200200305A (et) Südame arütmiate ravis kasutatavad uued asabitsüklooktaani derivaadid
MA27202A1 (fr) Composition pour le traitement de tissus comprenant un agent permettant d'ameliorer l'aspect de la solution de rincage
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
WO2002006280A3 (en) INHIBITORS OF FACTOR Xa
DE60201440D1 (de) Aryl-8-azabicyclo[3.2.1]octanes für die behandlung von depression
NO20004393D0 (no) Anvendelse av CD137 for Õ fremme proliferering av perifere monocytter
IS5231A (is) Vefjaþáttur sem hefur áhrif á blóðæðarmyndun
BR0303008A (pt) Composição detergente, método para lavar utensìlios de cozinha, e, kit
ATE226440T1 (de) Zusammensetzung zur behandlung von psoriasis
ATE261965T1 (de) Bispidin-derivate zur behandlung von herzarrhythmien
ATE270542T1 (de) Zusammensetzung zur verhinderung der keimbindung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application